dr. moore on the prevalence of ovarian cancer
Published 3 years ago • 173 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
2:43
dr. moore on the impact of solo-1 in ovarian cancer
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
1:50
dr. moore on results of the forward i/gog 3011 trial in ovarian cancer
-
2:09
dr. moore on the nova trial for ovarian cancer
-
1:22
dr. copeland on the prevalence of ovarian cancer in the united states
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
2:32
dr. moore on research evaluating repeat exposure to parp inhibition in ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
2:20
dr. moore on the results of the nova trial in ovarian cancer
-
1:34
dr. moore on challenges with immunotherapy in ovarian cancer
-
1:16
dr. moore discusses combinations in ovarian cancer
-
1:40
dr. moore on immunotherapy and parp combinations in brca-mutated ovarian cancer
-
5:07
improvements in advanced ovarian cancer
-
2:43
an introduction to the discussion of ovarian cancer
-
1:13:10
the state of ovarian cancer: exploring the landscape of systemic therapy